ADC Therapeutics

ADCT

Börsenwert 192 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	61,1 Mio. $	–	–	–
2	2 Redmile Group San Francisco, California	59,7 Mio. $	+753.104 $	+79.600	+1 %
3	3 JP Morgan Chase New York	27,5 Mio. $	+369.380 $	+39.042	+1 %
4	4 AllianceBernstein Nashville, Tennessee	23,5 Mio. $	+43.218 $	+4.568	+0,2 %
5	5 T. Rowe Price Associates Baltimore, Maryland	15,6 Mio. $	-4,74 Mio. $	-501.426	-20 %
6	6 Eventide Asset Management Boston, Massachusetts	14,9 Mio. $	-899.192 $	-95.041	-5 %
7	7 GCM Grosvenor Holdings Chicago, Illinois	10,3 Mio. $	+12,3 Mio. $	+1.298.012	Neu
8	8 Pictet Asset Management (Switzerland) Geneva 73, Switzerland	10,3 Mio. $	–	–	–
9	9 Vantage Consulting Group Virginia Beach, Virginia	9,43 Mio. $	-4,67 Mio. $	-493.934	-29 %
10	10 Walleye Capital New York	7,06 Mio. $	+6,06 Mio. $	+640.346	+258 %
11	11 HHLR Advisors Grand Cayman, Cayman Islands	3,98 Mio. $	–	–	–
12	12 BlackRock New York	3,71 Mio. $	+1,54 Mio. $	+162.575	+53 %
13	13 American Century Companies Kansas City, Missouri	3,59 Mio. $	+288.847 $	+30.530	+7 %
14	14 Principal Financial Group Des Moines, Iowa	3,23 Mio. $	+954.209 $	+100.856	+33 %
15	15 Matrix Capital Management Company Portsmouth, New Hampshire	3,18 Mio. $	–	–	–
16	16 MPM BioImpact Boston, Massachusetts	2,66 Mio. $	–	–	–
17	17 Employees Retirement System of Texas Austin, Texas	2,48 Mio. $	–	–	–
18	18 Morgan Stanley New York	1,63 Mio. $	+1,13 Mio. $	+119.703	+139 %
19	19 Magnetar Financial Evanston, Illinois	1,33 Mio. $	–	–	–
20	20 ExodusPoint Capital Management New York	1,11 Mio. $	+1,32 Mio. $	+139.192	Neu
21	21 Indie Asset Partners Carmel, Indiana	747.000 $	-24.438 $	-2.583	-3 %
22	22 TD Asset Management Toronto, Ontario, Canada	734.000 $	–	–	–
23	23 Balyasny Asset Management Chicago, Illinois	684.000 $	+814.601 $	+86.100	Neu
24	24 Ameriprise Minneapolis, Minnesota	636.000 $	+46.795 $	+4.946	+7 %
25	25 Renaissance Technologies New York	635.000 $	+755.942 $	+79.900	Neu

ADC Therapeutics ADCT Börsenwert 192 Mio. $

ADC Therapeutics

ADCT

Börsenwert 192 Mio. $